🏛️ Verified NIH Record • Updated 2026-07-20
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder (NCT06021522)
A Multicenter, Open-Label, Study to Evaluate the Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Emalex Biosciences Inc.
🩺 Plain-English Summary (8th-Grade Level)
The primary objective of this study is to evaluate the long-term safety and tolerability of ecopipam tablets in children (greater than or equal to \[\>=\] 6 and less than \[\<\] 12 years of age), adolescents (\>=12 and \<18 years of age), and adults (\>=18 years of age) with Tourette's Syndrome (TS).
Who can join: Review the eligibility criteria below.
Location: Harmonex, Inc. — Dothan, Alabama
Age range: 6 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (67 Sites)
Showing the first 25 of 67 sites.
- Harmonex, Inc. — Dothan, Alabama
- Arkansas Children's Hospital — Little Rock, Arkansas
- Advanced Research Center — Anaheim, California
- CenExel CIT-IE — Bellflower, California
- Cortica Site Network — Glendale, California
- Cortica Site Network - San Rafael — San Rafael, California
- Yale School of Medicine — New Haven, Connecticut
- Childrens National Hospital — Washington D.C., District of Columbia
- NW FL Clinical Research Group, LLC — Gulf Breeze, Florida
- Research in Miami Inc — Hialeah, Florida
- University of Miami Miller School of Medicine — Miami, Florida
- Florida International Research Center — Miami, Florida
- Medical Research Group of Central Florida — Orange City, Florida
- APG Research, LLC — Orlando, Florida
- University of South Florida — St. Petersburg, Florida
- Pediatric Epilepsy and Neurology Specialists — Tampa, Florida
- Rare Disease Research, LLC — Atlanta, Georgia
- Lurie Children Hospital of Chicago — Chicago, Illinois
- Rush University Medical Center — Chicago, Illinois
- Josephson-Wallack-Munshower Neurology — Indianapolis, Indiana
- University of Louisville Research Foundation Inc. — Louisville, Kentucky
- Kennedy Krieger Institute — Baltimore, Maryland
- Mass General Hospital — Boston, Massachusetts
- Boston Childrens Hospital — Boston, Massachusetts
- Umass Chan Medical School — Worcester, Massachusetts
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Tourette Syndrome
- Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome — Sun City, Arizona
- Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression — Gainesville, Florida
- SCI-110 in the Treatment of Tourette Syndrome — New Haven, Connecticut
- Trajectories of Change in Tourette Syndrome — Minneapolis, Minnesota
- Sensory Symptoms in Tourette Syndrome — Nashville, Tennessee
Explore by condition: All Tourette Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.